https://bioinformatics.umg.eu/onkopus/drugon#immunotherapy
Properties
- label
- [] immunotherapy
Parents
Children
Relations
- is_mesh
- blinatumomab
- is_mesh
- moxetumomabpasudotox
- is_mesh
- alemtuzumab
- is_mesh
- ramucirumab
- is_mesh
- brexucabtageneautoleucel
- is_mesh
- obinutuzumab
- is_mesh
- tebentafusp
- is_mesh
- antilymphocyteimmunoglobulinhorse
- is_mesh
- peginterferonalfa2b
- is_mesh
- sipuleucelt
- is_mesh
- siltuximab
- is_mesh
- tisagenlecleucel
- is_mesh
- humanpapillomavirustype18l1capsidproteinantigen
- is_mesh
- anakinra
- is_mesh
- tafasitamab
- is_mesh
- ruxolitinib
- is_mesh
- ipilimumab
- is_mesh
- mosunetuzumab
- is_mesh
- belantamabmafodotin
- is_mesh
- hepatitisbvaccinerecombinant
- is_mesh
- edrecolomab
- is_mesh
- sarilumab
- is_mesh
- isatuximab
- is_mesh
- humanpapillomavirustype45l1capsidproteinantigen
- is_mesh
- ibrutinib
- is_mesh
- atezolizumab
- is_mesh
- imlifidase
- is_mesh
- interferonalfa2b
- is_mesh
- secukinumab
- is_mesh
- sirolimus
- is_mesh
- certolizumabpegol
- is_mesh
- naxitamab
- is_mesh
- polatuzumabvedotin
- is_mesh
- brentuximabvedotin
- is_mesh
- mifamurtide
- is_mesh
- dinutuximab
- is_mesh
- siponimod
- is_mesh
- mogamulizumab
- is_mesh
- avelumab
- is_mesh
- pexidartinib
- is_mesh
- cetuximab
- is_mesh
- aldesleukin
- is_mesh
- inotuzumabozogamicin
- is_mesh
- risankizumab
- is_mesh
- trastuzumabemtansine
- is_mesh
- humanpapillomavirustype16l1capsidproteinantigen
- is_mesh
- rituximab
- is_mesh
- interferonalfa2a
- is_mesh
- humanpapillomavirustype33l1capsidproteinantigen
- is_mesh
- pomalidomide
- is_mesh
- pentostatin
- is_mesh
- methotrexate
- is_mesh
- ropeginterferonalfa2b
- is_mesh
- imatinib
- is_mesh
- nivolumab
- is_mesh
- belinostat
- is_mesh
- antithymocyteimmunoglobulinrabbit
- is_mesh
- imiquimod
- is_mesh
- denileukindiftitox
- is_mesh
- humanpapillomavirustype58l1capsidproteinantigen
- is_mesh
- necitumumab
- is_mesh
- sirukumab
- is_mesh
- enfortumabvedotin
- is_mesh
- efalizumab
- is_mesh
- elotuzumab
- is_mesh
- trastuzumabderuxtecan
- is_mesh
- bcgvaccine
- is_mesh
- ibritumomabtiuxetan
- is_mesh
- pertuzumab
- is_mesh
- olaratumab
- is_mesh
- eculizumab
- is_mesh
- pembrolizumab
- is_mesh
- idelalisib
- is_mesh
- cemiplimab
- is_mesh
- vedolizumab
- is_mesh
- catumaxomab
- is_mesh
- bevacizumab
- is_mesh
- humanpapillomavirustype31l1capsidproteinantigen
- is_mesh
- lisocabtagenemaraleucel
- is_mesh
- ravulizumab
- is_mesh
- axicabtageneciloleucel
- is_mesh
- talimogenelaherparepvec
- is_mesh
- azathioprine
- is_mesh
- daclizumab
- is_mesh
- trastuzumab
- is_mesh
- humanpapillomavirustype11l1capsidproteinantigen
- is_mesh
- humanpapillomavirustype52l1capsidproteinantigen
- is_mesh
- panitumumab
- is_mesh
- rilonacept
- is_mesh
- sacituzumabgovitecan
- is_mesh
- denosumab
- is_mesh
- daratumumab
- is_mesh
- everolimus
- is_mesh
- durvalumab
- is_mesh
- gemtuzumabozogamicin
- is_mesh
- humanpapillomavirustype6l1capsidproteinantigen
- is_mesh
- idecabtagenevicleucel
- is_mesh
- ofatumumab
- is_mesh
- apremilast